Current Status of the Safety and Efficacy of Antidotes for Direct Oral Anticoagulants in Japan. [PDF]
Kodani E.
europepmc +1 more source
Anticoagulation Stewardship Program in the DOAC Era. [PDF]
Ng JX, Tan SC, Koh PL, Yap ES.
europepmc +1 more source
Research Advances in Timing of Anticoagulant Therapy Following Cardioembolic Stroke. [PDF]
Rousidanmu M, Yang N, Yang P, Yan N.
europepmc +1 more source
Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort. [PDF]
Tan SSN +10 more
europepmc +1 more source
Dabigatran prevents lipopolysaccharide mediated apoptosis in zebrafish through a thrombin independent mechanism. [PDF]
Fleischmann AIT +8 more
europepmc +1 more source
Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]
Chai H, Huo J, Chen H.
europepmc +1 more source
Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.
Bradley MC +5 more
europepmc +1 more source
Changes in the use of vitamin K antagonists and direct oral anticoagulants and impact on the incidence of oral anticoagulation-related intracerebral hemorrhage: population-wide prescription patterns in two 5-year cohorts. [PDF]
Tomppo L +7 more
europepmc +1 more source
Safety and Efficacy of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Cerebrovascular Ischemic Outcomes in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]
Nasir A +8 more
europepmc +1 more source

